Rodent Models of Stroke

Rodent Models of Stroke

Series: Neuromethods, Vol. 47

Dirnagl, Ulrich (Ed.)

1st Edition., XII, 285 p. 49 illus.

A product of Humana Press


Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke.

Wyseure T, Rubio M, Denorme F, Martinez de Lizarrondo S, Peeters M, Gils A, De Meyer SF, Vivien D, Declerck PJ.Blood. 2015 Feb 19;125(8):1325-32. doi: 10.1182/blood-2014-07-588319. Epub 2014 Dec 24.

 

Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice.

Joshi AU, Orset C, Engelhardt B, Baumgart-Vogt E, Gerriets T, Vivien D, Kanse SM. Eur J Neurosci. 2015 Jan 23. doi: 10.1111/ejn.12830. [Epub ahead of print]

 

Molecular magnetic resonance imaging of brain-immune interactions.

Gauberti M, Montagne A, Quenault A, Vivien D. Front Cell Neurosci. 2014 Nov 27;8:389. doi: 10.3389/fncel.2014.00389. eCollection 2014. Review.

 

Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis?

Gaberel T, Gakuba C, Goulay R, Martinez De Lizarrondo S, Hanouz JL, Emery E, Touze E, Vivien D, Gauberti M. Stroke. 2014 Oct;45(10):3092-6. doi:10.1161/STROKEAHA.114.006617. Epub 2014 Sep 4.

 

Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.

Gaberel T, Montagne A, Lesept F, Gauberti M, Lemarchand E, Orset C, Goulay R, Bertrand T, Emery E, Vivien D.Neuropharmacology. 2014 Oct;85:158-65. doi: 10.1016/j.neuropharm.2014.05.001. Epub 2014 May 15.


GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice.

Le Behot A, Gauberti M, Martinez De Lizarrondo S, Montagne A, Lemarchand E, Repesse Y, Guillou S, Denis CV, Maubert E, Orset C, Vivien D.Blood. 2014 May 22;123(21):3354-63. doi: 10.1182/blood-2013-12-543074. Epub 2014 Feb 19.

 

Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates.

Gauberti M, Martinez de Lizarrondo S, Orset C, Vivien D. J Thromb Haemost. 2014;12(3):409-14. doi: 10.1111/jth.12487.

 

Intracerebral hematomas disappear on T2*-weighted images during normobaric oxygen therapy.

Gaberel T, Gakuba C, Hebert M, Montagne A, Agin V, Rubio M, Emery E, Vivien D, Gauberti M.Stroke. 2013 Dec;44(12):3482-9. doi: 10.1161/STROKEAHA.113.002045. Epub 2013 Oct 8. 

 

Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes.

Gauberti M, Montagne A, Marcos-Contreras OA, Le Béhot A, Maubert E, Vivien D.Stroke. 2013 Jul;44(7):1988-96. doi: 10.1161/STROKEAHA.111.000544. Epub 2013 Jun 6.

 

Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome.

Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, Touze E, Agin V, Emery E, Ali C, Vivien D.Neuropharmacology. 2013 Apr;67:267-71. doi: 10.1016/j.neuropharm.2012.11.023. Epub 2012 Dec 3.


Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.

El Amki M, Lerouet D, Coqueran B, Curis E, Orset C, Vivien D, Plotkine M, Marchand-Leroux C, Margaill I.Exp Neurol. 2012 Dec;238(2):138-44. doi: 10.1016/j.expneurol.2012.08.005. Epub 2012 Aug 19.


Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI--a pilot study.
Gauberti M, Obiang P, Guedin P, Balossier A, Gakuba C, Diependaele AS, Chazalviel L, Vivien D, Young AR, Agin V, Orset C.
Cerebrovasc Dis. 2012;33(4):329-39. doi: 10.1159/000335309.



Memantine improves safety of thrombolysis for stroke.
Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M, Gauberti M, Orset C, Ali C, Agin V, Maubert E, Vivien D.
Stroke. 2012 Oct;43(10):2774-81. Epub 2012 Aug 9.

 
Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH.
PLoS One
. 2012;7(2):e30934. doi: 10.1371/journal.pone.0030934. Epub 2012 Feb 22.


Prothrombolytic action of normobaric oxygen given alone or in combination with recombinant tissue-plasminogen activator in a rat model of thromboembolic stroke.
David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH.
J Appl Physiol
. 2012 Jun;112(12):2068-76. doi: 10.1152/japplphysiol.00092.2012. Epub 2012 Apr 5.

 
Interactions between nitrous oxide and tissue plasminogen activator in a rat model of thromboembolic stroke.

Haelewyn B, David HN, Colloc'h N, Colomb DG Jr, Risso JJ, Abraini JH.
Anesthesiology. 2011 Nov;115(5):1044-53. doi: 10.1097/ALN.0b013e3182342860.

 
Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia.
David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH.
J Cereb Blood Flow Metab
. 2009 Jun;29(6):1159-65. doi: 10.1038/jcbfm.2009.40. Epub 2009 Apr 22.

 
Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.
Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, Cassé F, Hommet Y, Orset C, Agin V, Bezin L, Berrocoso TG, Petersen KU, Montaner J, Maubert E, Vivien D, Ali C.
Stroke
. 2011 Aug;42(8):2315-22. doi: 10.1161/STROKEAHA.110.606293. Epub 2011 Jun 16.

 
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, Parks WC, Birkland TP, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E, Páramo JA.
Circulation
. 2011 Dec 20;124(25):2909-19. doi: 10.1161/CIRCULATIONAHA.111.047100. Epub 2011 Nov 21.

 
Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?

Haelewyn B, Risso JJ, Abraini JH.
J Cereb Blood Flow Metab
. 2010 May;30(5):900-3. doi: 10.1038/jcbfm.2010.33. Epub 2010 Mar 10.

 
Neuroprotection by nitrous oxide: facts and evidence.

Haelewyn B, David HN, Rouillon C, Chazalviel L, Lecocq M, Risso JJ, Lemaire M, Abraini JH.
Crit Care Med. 2008 Sep;36(9):2651-9. doi: 10.1097/CCM.0b013e318183f646.

 
Mouse model of in situ thromboembolic stroke and reperfusion.

Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D.
Stroke
. 2007 Oct;38(10):2771-8. Epub 2007 Aug 16.


CURB
Bd Henri Becquerel
14000 CAEN
FRANCE

02 31 56 68 81
esrp@cyceron.fr

IBISAUCBNINSERMESRP